Q-Line Biotec Limited SME IPO: Price, GMP, Dates & Review

By /
Q-Line Biotec Limited IPO
QL
Q-Line Biotec Limited IPO
Diagnostic Healthcare · IVD Reagents & Devices · Lucknow Plant · R&D Driven
📋 SME IPO Fresh Issue NSE SME
₹343
Upper Price
₹214.48 Cr
Issue Size
May 29, 2026
Listing Date
TBD
Market Cap
📅 IPO Timetable
All dates tentative
🟢
IPO Opens
Thursday, 21 May 2026
Bidding starts — apply before close
🔒
IPO Closes
Monday, 25 May 2026
Last day to bid — closes at 5:00 PM IST
📊
Tuesday, 26 May 2026
Allotment finalised by registrar
🔄
Wednesday, 27 May 2026
Unallotted funds returned; shares credited to demat
🏷️
Friday, 29 May 2026
Trading begins from 10:00 AM IST
📋 IPO Details
IPO Open Date21 May 2026 (Thu)
IPO Close Date25 May 2026 (Mon)
Listing Date29 May 2026 (Fri)
Face Value₹10 per share
Price Band₹326 to ₹343
Issue Price (Upper Band)₹343 per share
Issue TypeBook Build — Fresh Issue
Lot Size400 shares
Total Issue Size62,53,200 shares (₹214.48 Cr)
Fresh Issue62,53,200 shares (₹214.48 Cr)
Market Maker Shares3,13,200 shares
Pre-Issue Shares1,70,74,999
Post-Issue Shares2,33,28,199
Promoter Holding (Pre)96.77%
Lead ManagerHem Securities Ltd.
RegistrarPurva Sharegistry (India)
💰 Lot Size & Minimum Investment
At upper price ₹343
Investor TypeLotsSharesAmount
Retail — Minimum & Maximum2800₹2,74,400
S-HNI (sNII) — Min31,200₹4,11,600
S-HNI (sNII) — Max72,800₹9,60,400
B-HNI (bNII) — Min83,200₹10,97,600
⚠️ SME IPO Note: Minimum application for retail is 2 lots (800 shares = ₹2,74,400). Retail maximum limit is also 2 lots. Lot size is 400 shares; bids must be in multiples thereof.
👥 Investor Reservation
Total 62,53,200 shares
49.99%
QIB Portion
29,69,200 shares
35.00%
Retail (RII)
20,79,200 shares
15.01%
NII / HNI
8,91,600 shares
💡 Market Maker: Hem Finlease Pvt.Ltd. has been allocated 3,13,200 shares (5.01% of issue) to ensure liquidity post-listing.
📊 Live Subscription Status
Bidding Live

The Q-Line Biotec IPO is subscribed 2.11 times on May 21, 2026 12:04:03 PM (Day 1).

CategoryShares OfferedShares Bid ForSubscription (x)
QIB (Ex Anchor)11,88,00041,58,8003.50x
NII / HNI8,91,60015,52,0001.74x
Retail Investors20,79,20030,68,8001.48x
Total Public41,58,80087,79,6002.11x

Total Applications: 4,528 · Market Maker portion excluded from NII.

📈 Company Financials
Restated Consolidated · ₹ Crore
Metric31 Dec 202531 Mar 202531 Mar 202431 Mar 2023
Total Assets561.34455.49339.25251.58
Total Income236.50322.58206.45184.81
PAT38.6928.1334.4432.10
EBITDA64.2371.3237.6332.98
Net Worth-0.04189.95161.81127.37
Total Borrowing243.85164.9596.9173.65
Income Growth
FY 2023–24₹206.45 Cr
FY 2024–25₹322.58 Cr
H1 FY26 (Dec 2025)₹236.50 Cr
🎯 Key Performance Indicators
17.66%
ROE
FY 2024–25
23.74%
ROCE
FY 2024–25
8.97%
PAT Margin
FY 2024–25
0.87
Debt/Equity
FY 2024–25
16.88%
ROE (H1 FY26)
Dec 31, 2025
13.32%
ROCE (H1 FY26)
Dec 31, 2025
16.65%
PAT Margin
Dec 31, 2025
1.06
Debt/Equity
Dec 31, 2025
⚖️ Valuation & EPS
Price to Book Value
TBD
At upper price band
Market Cap (Post-IPO)
TBD
At issue price ₹343
🎯 Objects of the Issue
Net proceeds utilisation
1
To meet working capital requirements
₹93.50 Cr
2
Repayment of certain borrowing availed by the Company, in part or full
₹90.00 Cr
Total Net Proceeds Target ₹183.50 Cr
🏢 About Q-Line Biotech Limited
Est. 2010 · Lucknow, Uttar Pradesh · Diagnostic Healthcare Needs

Q-Line Biotech Limited is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, and distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

The company supplies diagnostic equipment and IVD products directly or through distributors majorly to diagnostic service providers, hospitals and medical colleges. Its key manufacturing segments include indigenous manufacturing of reagents (Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Others) and supplying/manufacturing of in-vitro diagnostics (IVD) and Pathology equipment.

Competitive Strengths
✅Established manufacturing capabilities with focus on R&D, Reverse Engineering and quality control
📍Diversified product portfolio with focus on IVD industry
📋Widespread distribution network with a presence across all four regions
👨‍💼Long standing relationships with customers and experienced Promoter team
Company Promoters
SG
Saurabh Garg
Promoter, Q-Line Biotech Limited
AG
Amita Garg
Promoter, Q-Line Biotech Limited
📅 Key Dates
IPO Opens21 May 2026
IPO Closes25 May 2026
Allotment26 May 2026
Refund & Share Credit27 May 2026
Listing Day29 May 2026
💡 Quick Summary
Price Band₹326 – ₹343
Issue Price₹343 / share
Lot Size400 shares
Min. Investment (Retail)₹2,74,400 (2 lots)
Issue Size₹214.48 Cr
ListingNSE SME
🏦 Registrar & Lead Manager
Registrar
Purva Sharegistry (India) Pvt.Ltd.
📞 +91-022-23018261/ 23016761
[email protected]
Lead Manager
Hem Securities Ltd.
Market Maker
Hem Finlease Pvt.Ltd.
📍 Registered Address
Q-Line Biotech Ltd.
298-281, Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station,
Lucknow, Uttar Pradesh — 226012
📞 +91 522-2435570
[email protected]
🛡️ Regulatory Note: SME IPO investments are subject to SEBI regulations. Always read the Prospectus/RHP before applying. Consult a SEBI-registered advisor before investing.
⚠️ Disclaimer: This page presents publicly available information from the Q-Line Biotec IPO RHP for informational purposes only. It does not constitute investment advice. IPO investments are subject to market risk. Please read all offer documents and consult a SEBI-registered advisor before investing.
📊
Track Q-Line Biotec Limited SME IPO: Price, GMP, Dates & Review GMP
Check real-time grey market premium, daily GMP history & estimated listing price.
Check GMP →

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top